Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer-Reference-Cited by-同舟云学术

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer

Published:2019-09 Issue: Volume:47 Page:184-194
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Yu Yu^ORCID,Suryo Rahmanto Yohan,Shen Yao-An,Ardighieri Laura^ORCID,Davidson Ben,Gaillard Stephanie,Ayhan Ayse^ORCID,Shi Xu^ORCID,Xuan Jianhua,Wang Tian-Li,Shih Ie-Ming

Funder

Richard W. TeLinde Gynecologic Laboratory

Department of Gynecology and Obstetrics

Johns Hopkins University School of Medicine

NIH/NCI

Ovarian Cancer Research Foundation Alliance

HERA OSB

HERA Women's Cancer Foundation

Roseman Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference72 articles.

1. The dualistic model of ovarian carcinogenesis: Revisited, Revised, and Expanded;Kurman;Am J Pathol,2016

2. Integrated genomic analyses of ovarian carcinoma

3. Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers;Reyes;Mol Diagn Ther,2014

4. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma;Lassus;J Mol Med (Berl),2006

5. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review;Mehner;Genes Cancer,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines;Biomedicines;2023-08-28

2. Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A Comprehensive Review;Current Medicinal Chemistry;2023-04

3. Microplastics induce immune suppression via S100A8 downregulation;Ecotoxicology and Environmental Safety;2022-09

4. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis;Free Radical Biology and Medicine;2021-11

5. Development of a sensitive UHPLC–MS/MS method for the pharmacokinetics study of a novel tyrosine kinase inhibitors, 1‐[4‐(4‐{5‐Chloro‐4‐[2‐(propane‐2‐sulfonyl)‐phenylamino]‐pyrimidin‐2‐ylamino}‐phenyl)‐piperazin‐1‐yl]‐propenone in rats;Biomedical Chromatography;2021-01-15